Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Phase 2 Study of the Safety and Efficacy of Glufosfamide in Ovarian Cancer

NCT00442598 is registered in ClinicalTrials.gov with Eleison Pharmaceuticals LLC. as lead sponsor.

NCT NCT00442598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00442598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Phase 2 Study of the Safety and Efficacy of Glufosfamide in Ovarian Cancer
Lead sponsor
Eleison Pharmaceuticals LLC.
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2007
Completion date
April 30, 2008
Enrollment
17 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer